Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Theravance Biopharma (TBPH) Tax Rate (2018 - 2025)

Historic Tax Rate for Theravance Biopharma (TBPH) over the last 12 years, with Q3 2025 value amounting to 225.13%.

  • Theravance Biopharma's Tax Rate rose 2514500.0% to 225.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 53.83%, marking a year-over-year increase of 752300.0%. This contributed to the annual value of 43.43% for FY2024, which is 314100.0% down from last year.
  • According to the latest figures from Q3 2025, Theravance Biopharma's Tax Rate is 225.13%, which was up 2514500.0% from 25.09% recorded in Q2 2025.
  • In the past 5 years, Theravance Biopharma's Tax Rate registered a high of 225.13% during Q3 2025, and its lowest value of 158.42% during Q4 2024.
  • For the 5-year period, Theravance Biopharma's Tax Rate averaged around 2.35%, with its median value being 0.01% (2021).
  • In the last 5 years, Theravance Biopharma's Tax Rate tumbled by -887600bps in 2024 and then surged by 2514500bps in 2025.
  • Quarter analysis of 5 years shows Theravance Biopharma's Tax Rate stood at 0.35% in 2021, then tumbled by -57bps to 0.15% in 2022, then crashed by -47397bps to 69.66% in 2023, then plummeted by -127bps to 158.42% in 2024, then soared by 242bps to 225.13% in 2025.
  • Its Tax Rate stands at 225.13% for Q3 2025, versus 25.09% for Q2 2025 and 4.24% for Q1 2025.